Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients

Immunotherapy targeting programmed death receptor 1 and programmed death ligand 1 (PD-L1) has shown impressive antitumor efficacy in several solid cancers, including advanced hepatocellular carcinoma (HCC). Since response rates of various cancers to such immunotherapy appear to correlate with PD-L1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hepatocell Carcinoma
Main Authors: Zhong, Jian-Hong, Luo, Cheng-Piao, Zhang, Chun-Yan, Li, Le-Qun
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Commentary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5221808/
https://ncbi.nlm.nih.gov/pubmed/28116284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S122807
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados